Clopidogrel (Plavix)

ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.

Back to meds
CardiacHematologic / ImmuneNeuroneeds review

Clopidogrel (Plavix)

ATI class: Antiplatelet / P2Y12 receptor inhibitor

Action

  • ATI/source-folder candidate for Clopidogrel (Plavix); verify mechanism against the source table before validation.

Therapeutic use

  • Review under Coronary Artery Disease medication safety.

Nursing assessment

  • Assess bleeding, bruising, stool/urine blood, neurologic status, and fall risk.
  • Review stent history, upcoming procedures, and adherence.
  • Check concurrent anticoagulants, NSAIDs, and other antiplatelet therapy.

Administration

  • Verify route against the order and source table.

Side effects

  • Verify common side effects against the source table.

Adverse effects

  • Bleeding
  • GI bleeding
  • Intracranial hemorrhage
  • Thrombotic thrombocytopenic purpura rare
  • Rash

Interactions

  • Aspirin
  • NSAIDs
  • Anticoagulants
  • SSRIs/SNRIs
  • Omeprazole or esomeprazole may reduce activation

Contraindications

  • See source-specific contraindications and precautions before administration.

Precautions

  • Active pathological bleeding.
  • Use caution with bleeding disorders, recent surgery, trauma, severe liver disease, and planned invasive procedures.

Client teaching

  • Do not stop after stent placement unless the prescriber directs it.
  • Report black stools, vomiting blood, severe headache, unusual bruising, or uncontrolled bleeding.
  • Tell providers before procedures or dental work.

Medication outcomes

  • Therapeutic response with no priority adverse effects.

Antidote / rescue

  • No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.

NCLEX priority cues

  • Bleeding risk rises when combined with aspirin or anticoagulants.
  • Stopping early after stent can cause thrombosis.
  • Severe headache or neuro change can signal intracranial bleeding.

Medication classes

Antiplatelets

Source attribution

Google Drive source topic: Coronary Artery Disease
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed

Related study cards

Shows the medication class, ATI cues, source references, and connected study cards for this drug.

12 study links
Med classmedication class
Antiplatelets

Makes platelets less sticky so arterial clots are less likely to form.

ATI cuePrecaution
Active pathological bleeding.

ATI medication precaution concept.

ATI cueInteraction
Anticoagulants

ATI medication interaction concept.

ATI cueClass
Antiplatelet

ATI medication class concept.

ATI cueInteraction
Aspirin

ATI medication interaction concept.

ATI cueNursing Assessment
Assess bleeding, bruising, stool/urine blood, neurologic status, and fall risk.

ATI medication nursing assessment concept.

ATI cueMechanism of Action
ATI/source-folder candidate for Clopidogrel (Plavix); verify mechanism against the source table before validation.

ATI medication mechanism of action concept.

ATI cueAdverse Effect
Bleeding

ATI medication adverse effect concept.

ATI cueNCLEX Priority Cue
Bleeding risk rises when combined with aspirin or anticoagulants.

ATI medication nclex priority cue concept.

ATI cueNursing Assessment
Check concurrent anticoagulants, NSAIDs, and other antiplatelet therapy.

ATI medication nursing assessment concept.

ATI cueClient Teaching
Do not stop after stent placement unless the prescriber directs it.

ATI medication client teaching concept.

ATI cueAdverse Effect
GI bleeding

ATI medication adverse effect concept.